Abstract:Abstract Purpose: Prostate cancer is the second leading cause of cancer deaths among men in Western counties, which has also occurred in Chinese male with markedly increasing incidence in recent years. Although the mechanism underlying its progression still remains unclear, epigenetic modifications are important ethological parameters. The purpose of this study is to determine the methylation status and function of hypermethylatioted in cancer 1 (HIC1) in prostate cancer progression. Experimental Design: The methylation status of HIC1 promoter was assayed in cell lines, tissues, and plasma of patients with prostate cancer by using methylation-specific PCR and bisulfate sequencing PCR. The ability of HIC1 to regulate proliferation, migration, and invasion was assessed by MTT, scratch-healing assay, and reconstituted extracellular matrices in porous culture chambers. Tumorigenesis, metastases, and bone destruction were analyzed in mice bearing prostate cancer cells restoring HIC1 by using Xenogen IVIS with radiographic system and small-animal positron emission tomography computed tomographic images. Microarrays were searched for genes that had correlated expression with HIC1 mRNA. Reporter gene assays were used to determine whether HIC1 affected the expression of CXCR7, and chromatin immunoprecipitation was used to determine whether HIC1 bound to CXCR7 promoters. All P values were determined using 2-sided tests. Results: The methylation status of 11 CpG sites within HIC1 promoter was abundantly methylated in cell lines, tissues, and plasma of patients with prostate cancer compared with those of respective normal controls. Restoring HIC1 expression in prostate cancer cells markedly inhibited proliferation, migration, and invasion and induced the apoptosis in these cells. Moreover, mice bearing prostate cancer–restoring HIC1 cells had a marked effect on reducing tumor growth, multiple tissue metastases, and bone destruction. Notably, we also identified that the chemokine receptor CXCR7 is a direct downstream target gene of HIC1. Finally, we showed that CXCR7 promoter in prostate cancer cells is negatively regulated by HIC1, which may be responsible for prostate cancer progression. Conclusions: Our data show for the first time that hypermethylation of HIC1 promoter results in loss of its repressive function, responsible for prostate cancer progression and invasion. These findings suggest that therapies targeting epigenetic events regulating HIC1 expression may provide a more effective strategy for prostate cancer treatment. Clin Cancer Res; 19(6); 1400–10. ©2012 AACR.

Epigenetic Inactivation of Betaig-h3 Gene in Human Cancer Cells.

Aberrant DNA Methylation Associated with Silencing BNIP3 Gene Expression in Haematopoietic Tumours

Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation

Infrequently Methylated Event At Sites-362 To-142 In The Promoter Of Tgf Beta R1 Gene In Non-Small Cell Lung Cancer

Direct ChIP-bisulfite Sequencing Reveals a Role of H3K27me3 Mediating Aberrant Hypermethylation of Promoter CpG Islands in Cancer Cells.

Silence of HIN-1 Expression Through Methylation of Its Gene Promoter in Gastric Cancer

Supplementary Figure Legend from HIC1 Modulates Prostate Cancer Progression by Epigenetic Modification

Data from <i>CMTM3</i>, Located at the Critical Tumor Suppressor Locus 16q22.1, Is Silenced by CpG Methylation in Carcinomas and Inhibits Tumor Cell Growth through Inducing Apoptosis

Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma

Data from Epigenetic Silencing Mediated Through Activated PI3K/AKT Signaling in Breast Cancer

Hypermethylation of PGCP Gene is Associated with Human Bronchial Epithelial Cells Immortalization

Hic1 Modulates Prostate Cancer Progression By Epigenetic Modification

Epigenetic Silencing of a Proapoptotic Cell Adhesion Molecule, the Immunoglobulin Superfamily Member IGSF4, by Promoter CpG Methylation Protects Hodgkin Lymphoma Cells from Apoptosis.

Hypermethylation of Growth Arrest DNA Damage-Inducible Gene 45 Β Promoter in Human Hepatocellular Carcinoma

Akt Signaling Pathway Activated by Hin-1 Methylation in Non-Small Cell Lung Cancer

Signification of Hypermethylated in Cancer 1 (HIC1) as Tumor Suppressor Gene in Tumor Progression.

Hypermethylation of the PTTG1IP Promoter Leads to Low Expression in Early-Stage Non-Small Cell Lung Cancer

Effect of Antisense DNMT3b Gene Eukaryotic Expression Plasmid on Expression of the DNMT3b Gene in Human Biliary Tract Carcinoma Cells.

Changes in correlation between promoter methylation and gene expression in cancer

Methylated+322-327 Cpg Site Decreases Hogg1 Mrna Expression in Non-Small Cell Lung Cancer

DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis